ClinicalTrials.gg
Active, not recruitingNCT07298018Updated Oct 15, 2026

A Pilot Study of RISE for Nurse Managers Retreat

An interventional study of Intervention Group in Burnout, Secondary Traumatic Stress and Perceived Stress, sponsored by AdventHealth. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by AdventHealth · Not applicable, Interventional, and Other

How we know

Updated Oct 15, 2026Now Active, not recruitingStart date moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 149 studies in Burnout, Psychological with a site in United States — 29 open to participants now, 41 under way, none of them phase 3. Burnout, Psychological · United States.

Planned enrollment
118th of 134
16 · median 80
Started
2026
with 15 others
No phase
127 of 149
21 open now
Primary completion
2026-10
later than 13 of 40 live
Registered
133rd of 149
by date
Lead sponsor
8 of 149
AdventHealth

Among the 149 studies in Burnout, Psychological with a site in United States, this one is the 118th largest by planned enrollment of the 134 interventional ones that give a count, is one of 16 that started in 2026, is one of 127 with no phase, reaches primary completion later than 13 of the 40 other live ones, and was the 133rd registered.

Burnout, Psychological

468 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

Browse Burnout, Psychological studies →

Open to participants now

29 of the 149 studies in Burnout, Psychological with a site in United States are open now. Recruiting first, the newest first:

24 more — sign in →

All 29 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 65 Burnout, Psychological studies recruiting now, 43 (66%) set no upper age limit and 16 (25%) stop at 75 or younger; 14 take children under 18; 33 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 149 studies in Burnout, Psychological with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to determine the feasibility and acceptability of the RISE for Nurse Managers retreat and its impact on occupational and psychological well-being indicators

Read the detailed description

The RISE program is an empirically supported wellbeing intervention for nurses and nurse leaders delivered over 8 or 9 weeks in 90-minute weekly sessions facilitated by a licensed mental health professional. The program themes are Resilience, Insight, Self-Compassion, and Empowerment. This study will be to examine the feasibility and acceptability of delivering the program in a retreat style format over 2.5 days.

03

Conditions studied

  • Burnout
  • Secondary Traumatic Stress
  • Perceived Stress
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • an employed AdventHealth Nurse Manager
  • a "moderate" or "high" score in burnout equal to ≥17 in the Emotional Exhaustion Domain and/or ≥7 in the Depersonalization Domain on the MBI

Exclusion criteria

Exclusion Criteria:

  • a direct care RN, Nurse Director, Educator, and Executive
  • a "low" score in burnout equal to \<17 in the Emotional Exhaustion domain and/or \<7 in the Depersonalization domain on the MBI
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    Participant group

    Intervention group will attend the RISE Retreat program, which is a 2.5-day retreat-style psychoeducational group program facilitated by licensed mental health professionals (LMHPs)

    Behavioral: Intervention Group

Interventions

  • BehavioralIntervention Group

    Psychoeducational group program designed to impact occupational and psychological indicators including resilience, insight, self-compassion, empowerment, burnout and secondary trauma

06

What researchers measure

Primary outcomes

  1. Maslach Burnout Inventory - Human Services Survey

    22-item questionnaire with the following response categories: 0=never, 1=a few times a year or less, 2=once a month or less, 3=a few times a month, 4=once a week, 5=a few times a week, 6=every day. MBI includes 3 dimensions of Burnout: Emotional Exhaustion, Depersonalization, and Personal Accomplishment. There are 9 items included in Emotional Exhaustion and scores can range from 0-54. There are 5 items included in Depersonalization and scores can range from 0-30. There are 8 items included in Personal Accomplishment and scores can range from 0-48. Higher scores on Emotional Exhaustion and Depersonalization and lower scores on Personal Accomplishment are indicative of Burnout

    Time frame: Baseline, 1-month follow-up, 3-month follow-up, 6-month follow-up

Secondary outcomes

  1. Professional Quality of Life Scale

    30-item questionnaire with the following response categories: 1=never, 2=rarely, 3=sometimes, 4=often, 5=very often. PROQOL includes 3 dimensions: Compassion Satisfaction, Burnout, and Secondary Traumatic Stress. Each subscale includes 10 items and scores can range from 10-50. For Burnout and Secondary Traumatic Stress, lower scores are better. Sums of 10-22 = low level, 23-41 = average level, and 42-50=high level of Burnout and Secondary Traumatic Stress. For Compassion Satisfaction, higher scores are better. Sum of 10-22=low level, 23-41=average level, and 42-50=high level of Compassion Satisfaction.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  2. Brief Resilience Scale

    6-item questionnaire with the following response categories: 1=strongly agree, 2=disagree, 3=neutral, 4=agree, 5=strongly agree. Sum of items can range from 6-30, which is then divided by 6 to get an average score. Higher score is better, with 1-2.99 = low resilience, 3-4.3 = normal resilience, and 4.31-5.0 = high resilience.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  3. Self-Reflection and Insight Scale

    20-item questionnaire with the following response categories: 1=strongly disagree, 2, 3, 4, 5, 6=strongly agree. Six items are included in Self-Reflection and scores can range from 6-42, with higher scores indicating a greater self-reflection. Six items are included in Insight, and scores can also range from 6-42 with higher scores indicating more Insight.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  4. Self-Compassion Scale Short Form

    12-item questionnaire with the following response categories: 1=almost never, 2, 3, 4, 5=almost always. Scores are added and then averaged. While the average score is to be used comparatively, score 1.0-2.49 is considered low, 2.5-3.5 is considered moderate, and 3.51-5.0 is considered high.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  5. General Self-Efficacy Scale

    10-item questionnaire with the following response categories: 1=not at all true, 2=barely true, 3=moderately true, 4=exactly true. Item scores are added together and then averaged with higher scores indicating more self-efficacy.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  6. Perceived Stress Scale

    10-item questionnaire with the following response categories: 0=never, 1=almost never, 2=sometimes, 3=fairly often, 4=very often. The total score ranges from 0 to 40 with higher scores indicating greater perceived stress.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  7. Generalized Anxiety Disorder - 2 item scale

    2-item questionnaire with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Total score range is 0 to 6 and a score of 3 or higher suggests possible anxiety.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  8. Patient Health Questionnaire - 2 item

    2-item scale with the following response categories: 0=not at all, 1=several days, 2=more than half the days, 3=nearly every day. Total score range is from 0 to 6, and a score of 3 or more indicates possible depressed mood.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  9. Post-Traumatic Growth Inventory

    21-item scale scored using six-point responses: zero ("I did not experience this change as a result of my crisis") to five ("I experienced this change to a very great degree as a result of my crisis"). Total score range is 0 to 105, which higher scores indicating more post traumatic growth.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  10. Psychological Empowerment Instrument

    12-item measure that assesses empowerment in the workplace using a 7-point Likert response scale. Four aspects are measured: meaning, competence, self-determination, and impact. Total score range from 12 to 84, with higher scores indicating greater psychological empowerment.

    Time frame: Baseline, 1- and 3-and 6-month follow-up

  11. Employment Status

    Human Resources Data

    Time frame: 12-month post-program

07

Study locations

1 site
08

References and documents

Publications

  • Bailey AK, Sawyer AT, Robinson PS. A Psychoeducational Group Intervention for Nurses: Rationale, Theoretical Framework, and Development. J Am Psychiatr Nurses Assoc. 2023 May-Jun;29(3):232-240. doi: 10.1177/10783903211001116. Epub 2021 Jun 22. PubMed 34154451 ↗
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. PubMed 6668417 ↗
  • Kroenke K, Spitzer RL, Williams JB, Monahan PO, Lowe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007 Mar 6;146(5):317-25. doi: 10.7326/0003-4819-146-5-200703060-00004. PubMed 17339617 ↗
  • Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003 Nov;41(11):1284-92. doi: 10.1097/01.MLR.0000093487.78664.3C. PubMed 14583691 ↗
  • Litz BT, Plouffe RA, Nazarov A, Murphy D, Phelps A, Coady A, Houle SA, Dell L, Frankfurt S, Zerach G, Levi-Belz Y; Moral Injury Outcome Scale Consortium. Defining and Assessing the Syndrome of Moral Injury: Initial Findings of the Moral Injury Outcome Scale Consortium. Front Psychiatry. 2022 Jul 5;13:923928. doi: 10.3389/fpsyt.2022.923928. eCollection 2022. PubMed 35873252 ↗
  • Maslach C, Jackson SE, Leiter MP. Maslach Burnout Inventory manual, 3rd ed. Palo Alto, CA: Consulting Psychologists Press, 1996.
  • Raes F, Pommier E, Neff KD, Van Gucht D. Construction and factorial validation of a short form of the Self-Compassion Scale. Clin Psychol Psychother. 2011 May-Jun;18(3):250-5. doi: 10.1002/cpp.702. Epub 2010 Jun 8. PubMed 21584907 ↗
  • Sawyer AT, Bailey AK, Green JF, Sun J, Robinson PS. Resilience, Insight, Self-Compassion, and Empowerment (RISE): A Randomized Controlled Trial of a Psychoeducational Group Program for Nurses. J Am Psychiatr Nurses Assoc. 2023 Jul-Aug;29(4):314-327. doi: 10.1177/10783903211033338. Epub 2021 Jul 23. PubMed 34293934 ↗
  • Sawyer AT, Tao H, Bailey AK. The Impact of a Psychoeducational Group Program on the Mental Well-Being of Unit-Based Nurse Leaders: A Randomized Controlled Trial. Int J Environ Res Public Health. 2023 Jun 2;20(11):6035. doi: 10.3390/ijerph20116035. PubMed 37297639 ↗
  • Schwarzer, R., & Jerusalem, M. (1995). Generalized Self-Efficacy Scale. J. Weinman, S. Wright, & M. Johnston, Measures in health psychology: A user's portfolio. Causal and control beliefs, 35, 37.
  • Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972. PubMed 18696313 ↗
  • Spreitzer GM. Psychological empowerment in the workplace: Dimensions, measurement, and validation. Academy of Management Journal. 1995; 38(5):1442-1465.
  • Stamm, B. H. (2010). Professional Quality of Life: Compassion Satisfaction and Fatigue Version 5 (ProQOL). http://www.proqol.org.
  • Tedeschi RG, Calhoun LG. The Posttraumatic Growth Inventory: measuring the positive legacy of trauma. J Trauma Stress. 1996 Jul;9(3):455-71. doi: 10.1007/BF02103658. PubMed 8827649 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Oct 2026, 9 months after the start.

Of 253 non-industry interventional studies with no phase under Burnout, Psychological, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 9 months is below that.

Counting every sponsor, half of 260 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

Start moved once since we started tracking on Sep 25, 2026: Feb 2026 → Jan 2026, on Oct 15, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Dec 22, 2025
StartActual
Jan 29, 2026was Feb 2026
Primary completionEst.
Oct 31, 2026
CompletionEst.
Dec 16, 2026
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Active, not recruiting
changed Oct 15, 2026
Start date
Feb 1, 2026→Jan 29, 2026 (actual)
Oct 15, 2026
Primary completion
Oct 16, 2026→Oct 31, 2026
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Recruiting→Active, not recruiting
    Start date Feb 1, 2026→Jan 29, 2026 (now actual)
    Primary completion Oct 16, 2026→Oct 31, 2026
    + 3 other changes: verification date, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07298018
Lead sponsor
AdventHealth
Responsible party
Sponsor
First posted
Dec 22, 2025
Start date
Jan 29, 2026
Primary completion
Oct 31, 2026 (estimated)
Completion
Dec 16, 2026 (estimated)
Last update
Oct 15, 2026

Study contacts

Amanda T. Sawyer, PhD
principal investigator · AdventHealth

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion